Skip to main content
OpenTrials

Clinical trial condition

Asthma

Explore clinical trials studying Asthma. Study availability and eligibility vary by location and protocol.

3,550 public trials 275 recruiting studies
Refine in advanced search Browse all conditions

Asthma trial results

Completed

Study of the Ease of Use and Correct Use of Placebo ELLIPTA® Inhaler in Subjects With Asthma

NCT02586506

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • GSK Investigational Site Mobile, Alabama, United States
  • GSK Investigational Site Huntington Beach, California, United States
  • GSK Investigational Site Aventura, Florida, United States
  • GSK Investigational Site Miami, Florida, United States
View all 15 locations
View Trial Details
Completed

Evaluation of Umeclidinium Bromide in Combination With Fluticasone Furoate in COPD Subjects With an Asthmatic Component

NCT02164539

Conditions
Asthma, Bronchial Diseases, Chronic Disease, +11 more
Locations
  • GSK Investigational Site Newport Beach, California, United States
  • GSK Investigational Site San Diego, California, United States
  • GSK Investigational Site Upland, California, United States
  • GSK Investigational Site Sunset, Louisiana, United States
View all 67 locations
View Trial Details
Completed

A Study to Evaluate Efficacy and Safety of ADC3680 in Subjects With Inadequately-Controlled Asthma

NCT01730027

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Pulmagen Investigational Site Birmingham, Alabama, United States
  • Pulmagen Investigational Site Huntington Beach, California, United States
  • Pulmagen Investigational Site Riverside, California, United States
  • Pulmagen Investigational Site Rolling Hills, California, United States
View all 87 locations
View Trial Details
Completed

Evaluate the Safety, Efficacy and Dose Response of GSK573719 in Combination With Fluticasone Furoate in Subjects With Asthma

NCT01573624

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • GSK Investigational Site St Louis, Missouri, United States
  • GSK Investigational Site Medford, Oregon, United States
  • GSK Investigational Site Orangeburg, South Carolina, United States
  • GSK Investigational Site Spartanburg, South Carolina, United States
View all 32 locations
View Trial Details
Completed

Dose Ranging Study Evaluating the Efficacy and Safety of GSK2190915 Administered Once Daily

NCT01147744

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Huntington Beach, California, United States
  • GSK Investigational Site Newport Beach, California, United States
  • GSK Investigational Site San Diego, California, United States
View all 84 locations
View Trial Details

Related conditions